The results of a large clinical trial were promising; the gamma globulin was shown to be about 80 percent effective in preventing the development of paralytic poliomyelitis.
Os resultados do ensaio clínico realizado semellaban prometedores, demostrando que a gamma globulina tiña un 80% de efectividade na prevención do desenvolvemento de poliomielite paralizante.